BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3786243)

  • 1. [Sodium and potassium levels in the erythrocytes and blood serum in patients with bronchial asthma treated with triamcinolone acetonide].
    Staniszewska K; Jabłońska-Skwiecińska E; Garlicki A
    Pol Tyg Lek; 1986 Aug; 41(34):1063-4. PubMed ID: 3786243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum electrolyte, lipid, glucose and cortisol levels in patients with bronchial asthma treated with Kenalog].
    Chyrek-Borowska S; Obrzut D; Podkowicz K; Rublewska M; Szymański W; Zakrzewska I
    Przegl Lek; 1983; 40(4):397-400. PubMed ID: 6611998
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of triamcinolone acetonide in the treatment of severe intrinsic bronchial asthma.
    Romański B; Pawlik K; Wilewska-Klubo T
    Allergol Immunopathol (Madr); 1978; 6(4):321-4. PubMed ID: 735981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kenalog-40 (triamcinolone acetonide) in the treatment of severe infectious-allergic bronchial asthma].
    Chachaj W; Malolepszy J; Ceiślińska ; Kuczńskasekieta K
    Pol Tyg Lek; 1975 Jun; 30(25):1077-9. PubMed ID: 1135088
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of triamcinolone acetonide in the treatment of attacks of bronchial asthma].
    Higaki H; Sasaki Y; Mikami J
    Iryo; 1971 May; 25(5):319-24. PubMed ID: 5115158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the use of Intal and Kenalog 40 in patients with bronchial asthma (author's transl)].
    Szulczyńska K; Przeździakowa J; Bardzik I
    Przegl Lek; 1976; 33(4):482-7. PubMed ID: 818683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sodium and potassium in serum and sputum of patients with bronchial asthma].
    Sarnowska KM
    Pol Tyg Lek; 1971 Sep; 26(37):1424-6. PubMed ID: 5113278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetics of plasma cyclic AMP level in atopic and non-atopic bronchial asthma after administration of triamcinolone acetonide].
    Wasek Z; Lazowski J; Lypka A; Bogoniowska Z; Kruszewski J
    Pneumonol Pol; 1981; 49(8-9):577-83. PubMed ID: 6272235
    [No Abstract]   [Full Text] [Related]  

  • 9. Long acting triamcinolone acetonide in cases of bronchial asthma.
    Raj B; Chawla RK; Chopra RK
    Indian J Chest Dis Allied Sci; 1986; 28(4):189-96. PubMed ID: 3610245
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the behavior of intravascular granulocyte pools in bronchial asthma patients treated with Kenalog].
    Kruszewski J; Wasek Z; Markiewicz K
    Pneumonol Pol; 1981 Nov; 49(11):763-8. PubMed ID: 7342048
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mineral metabolism and the intensity of allergic reactions in bronchial asthma].
    Gaĭduk KK
    Sov Med; 1973 Nov; 36(11):139-40. PubMed ID: 4787411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse effect of the long-term use of triamcinolone acetonide in patients with bronchial asthma].
    Madalińska M; Droszcz W; Piotrowska B
    Pol Tyg Lek; 1988 May; 43(21):685-8. PubMed ID: 3226975
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protracted steroid therapy in asthma. II. Immunoglobulins in endogenic asthma].
    Płusa T; Wasek Z; Makowska U; Zborowski J
    Pneumonol Pol; 1980 Feb; 48(2):105-8. PubMed ID: 7367298
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary experience with triamcinolone acetonide during pregnancy.
    Dombrowski MP; Brown CL; Berry SM
    J Matern Fetal Med; 1996; 5(6):310-3. PubMed ID: 8972405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the effects of Kenalog and Zaditen on the clinical state and plasma cAMP levels of patients with bronchial asthma].
    Wasek Z; Malinowski R
    Pneumonol Pol; 1985 Feb; 53(2):85-90. PubMed ID: 2989803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum ACTH and cortisol levels in bronchial asthma during treatment with Kenalog].
    Lypka A; Wasek Z; Lazowski J; Bogoniowska Z
    Pneumonol Pol; 1981; 49(8-9):571-5. PubMed ID: 6272234
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors influencing adrenocortical suppression during long-term triamcinolone acetonide therapy in asthma.
    Droszcz W; Lech B; Malunowicz E; Piotrowska B
    Ann Allergy; 1980 Mar; 44(3):174-6. PubMed ID: 6767423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The behaviours of electrolyte, lipid and glucose levels in the blood serum of patients with bronchial asthma treated with kenalog (author's transl)].
    Gruszecka M; Podkowicz K; Rublewska R; Zakrzewska I
    Przegl Lek; 1977; 34(3):341-4. PubMed ID: 866725
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term triamcinolone acetonide aerosol treatment in adult patients with chronic bronchial asthma.
    Golub JR
    Ann Allergy; 1980 Mar; 44(3):131-7. PubMed ID: 6767422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term trials of aerosol triamcinolone acetonide in steroid-dependent asthma.
    Rowland V; Levine BE
    Ariz Med; 1977 Apr; 31(4):247-9. PubMed ID: 322647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.